Latest

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Jubbonti 60 mg solution for injection in pre-filled syringe EU/1/24/1813/001

Denosumab

—

Mycamine 100 mg powder for solution for infusion EU/1/08/448/002

Micafungin sodium

Sandoz Pharmaceuticals d.d.

—

Mycamine 50 mg powder for concentrate for solution for infusion EU/1/08/448/001

Micafungin sodium

Sandoz Pharmaceuticals d.d.

—

Omnitrope 1.3mg/ ml Powder and solvent for solution for injection EU/1/06/332/001

Somatropin

—

Omnitrope 10 mg/1.5 ml solution for injection in cartridge EU/1/06/332/007-009

Somatropin

—

Omnitrope 15 mg/1.5 ml solution for injection in cartridge EU/1/06/332/010-012

Somatropin

—

Omnitrope 5 mg/1.5 ml solution for injection in cartridge EU/1/06/332/004-006

Somatropin

—

Omnitrope 5mg/ ml Powder and solvent for solution for injection EU/1/06/332/002-003

Somatropin

—

Ondibta 100 units/ml solution for injection in pre-filled pen EU/1/25/2000/001-003

Insulin glargine

—

Pregabalin Sandoz 100 mg hard capsules EU/1/15/1011/034-041

Pregabalin

—

Pregabalin Sandoz 150 mg hard capsules EU/1/15/1011/042-056

Pregabalin

—

Pregabalin Sandoz 200 mg hard capsules EU/1/15/1011/057-062

Pregabalin

—

Pregabalin Sandoz 225 mg hard capsules EU/1/15/1011/063-068

Pregabalin

—

Pregabalin Sandoz 25 mg hard capsules EU/1/15/1011/001-010

Pregabalin

—

Pregabalin Sandoz 300 mg hard capsules EU/1/15/1011/069-083

Pregabalin

—

Pregabalin Sandoz 50 mg hard capsules EU/1/15/1011/011-017

Pregabalin

—

Pregabalin Sandoz 75 mg hard capsules EU/1/15/1011/018-033

Pregabalin

—

Pregabalin Sandoz GmbH 100 mg hard capsules EU/1/15/1012/034-041

Pregabalin

—

Pregabalin Sandoz GmbH 150 mg hard capsules EU/1/15/1012/042-056

Pregabalin

—

Pregabalin Sandoz GmbH 200 mg hard capsules EU/1/15/1012/057-062

Pregabalin

—

Pregabalin Sandoz GmbH 225 mg hard capsules EU/1/15/1012/063-068

Pregabalin

—

Pregabalin Sandoz GmbH 25 mg hard capsules EU/1/15/1012/001-010

Pregabalin

—

Pregabalin Sandoz GmbH 300 mg hard capsules EU/1/15/1012/069-083

Pregabalin

—

Pregabalin Sandoz GmbH 50 mg hard capsules EU/1/15/1012/011-017

Pregabalin

—

Pregabalin Sandoz GmbH 75 mg hard capsules EU/1/15/1012/018-033

Pregabalin

—

Rivastigmine Sandoz 1.5 mg hard capsules EU/1/09/599/001-003

Rivastigmine hydrogen tartrate

Sandoz Pharmaceuticals GmbH

—

Rivastigmine Sandoz 2 mg/ml oral solution EU/1/09/599/017-018

Rivastigmine hydrogen tartrate

Sandoz Pharmaceuticals GmbH

—

Rivastigmine Sandoz 3 mg hard capsules EU/1/09/599/005-007

Rivastigmine hydrogen tartrate

Sandoz Pharmaceuticals GmbH

—

Rivastigmine Sandoz 4.5 mg hard capsules EU/1/09/599/009-011

Rivastigmine hydrogen tartrate

Sandoz Pharmaceuticals GmbH

—

Rivastigmine Sandoz 6 mg hard capsules EU/1/09/599/013-015

Rivastigmine hydrogen tartrate

Sandoz Pharmaceuticals GmbH

—

Rixathon 100 mg concentrate for solution for infusion EU/1/17/1185/001-002

Rituximab

—

Rixathon 500 mg concentrate for solution for infusion EU/1/17/1185/003-004

Rituximab

—

Riximyo 100 mg concentrate for solution for infusion EU/1/17/1184/001-002

Rituximab

—

Riximyo 500 mg concentrate for solution for infusion EU/1/17/1184/003-004

Rituximab

—

Rolcya 60 mg solution for injection in pre-filled syringe EU/1/25/1958/001

Denosumab

—

Transiderm-Nitro 10milligram/24 hours Transdermal Patch PA23311/005/002

Glyceryl trinitrate

Sandoz Pharmaceuticals d.d.

Marketed

Transiderm-Nitro 15milligrams/24 hours Transdermal Patch PA23311/005/003

Glyceryl trinitrate

Sandoz Pharmaceuticals d.d.

Marketed

Transiderm-Nitro 5milligrams/24 hours Transdermal Patch PA23311/005/001

Glyceryl trinitrate

Sandoz Pharmaceuticals d.d.

Marketed

Wyost 120 mg solution for injection EU/1/24/1812/001

Denosumab

—

Zarzio 30 MU (60 MU/ml) Solution for injection or EU/1/08/495/1-4,9-12

Ep2006 (recombinant human granulocyte-colony stimulating factor)

—

Zarzio 48 MU (96 MU/ml) Solution for injection or EU/1/08/495/5-8,13-16

Ep2006 (recombinant human granulocyte-colony stimulating factor)

—

Zessly 100 mg powder for concentrate for solution for infusion EU/1/18/1280/001-005

Infliximab

—

Ziextenzo 6 mg solution for injection in pre-filled syringe EU/1/18/1327/001

Pegfilgrastim

—

Zinacef 1.5 g powder for solution for injection or infusion PA23311/002/003

Cefuroxime Sodium

Sandoz Pharmaceuticals d.d.

Marketed

Zinacef 250 mg powder for solution for injection or infusion PA23311/002/001

Cefuroxime Sodium

Sandoz Pharmaceuticals d.d.

Marketed

Zinacef 750 mg powder for solution for injection or infusion PA23311/002/002

Cefuroxime Sodium

Sandoz Pharmaceuticals d.d.

Marketed

Zinnat 125 mg film-coated tablets PA23311/003/002

Cefuroxime

Sandoz Pharmaceuticals d.d.

Marketed

Zinnat 125 mg/5 ml granules for oral suspension PA23311/003/005

Cefuroxime axetil

Sandoz Pharmaceuticals d.d.

Marketed

Zinnat 250 mg film-coated tablets PA23311/003/003

Cefuroxime

Sandoz Pharmaceuticals d.d.

Marketed

Zinnat 250mg/5ml granules for oral suspension PA23311/003/001

Cefuroxime axetil

Sandoz Pharmaceuticals d.d.

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 29 September 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.